Cell‐type Selective Phototoxicity Achieved with Chlorophyll‐a Derived Photosensitizers in a Co‐culture System of Primary Human Tumor and Normal Lung Cells
- 28 August 2011
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 87 (6), 1405-1418
- https://doi.org/10.1111/j.1751-1097.2011.00992.x
Abstract
The ATP‐dependent transporter ABCG2 exports certain photosensitizers (PS) from cells, implying that the enhanced expression of ABCG2 by cancer cells may confer resistance to photodynamic therapy (PDT) mediated by those PS. In 35 patient‐derived primary cultures of lung epithelial and stromal cells, PS with different subcellular localization and affinity for ABCG2 displayed cell‐type specific retention both independent and dependent on ABCG2. In the majority of cases, the ABCG2 substrate 2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH) was lost from fibroblastic cells more rapidly than from their epithelial counterparts, even in the absence of detectable ABCG2 expression, facilitating selective eradication by PDT of epithelial over fibroblastic cells in tumor/stroma co‐cultures. Pairwise comparison of normal and transformed epithelial cells also identified tumor cells with elevated or reduced retention of HPPH, depending on ABCG2. Enhanced ABCG2 expression led to the selective PDT survival of tumor cells in tumor/stroma co‐cultures. This survival pattern was reversible through HPPH derivatives that are not ABCG2 substrates or the ABCG2 inhibitor imatinib mesylate. PS retention, not differences in subcellular distribution or cell signaling responses, was determining cell type selective death by PDT. These data suggest that up‐front knowledge of tumor characteristics, specifically ABCG2 status, could be helpful in individualized PDT treatment design.Keywords
This publication has 49 references indexed in Scilit:
- In Vitro Cellular Uptake and Dimerization of Signal Transducer and Activator of Transcription-3 (STAT3) Identify the Photosensitizing and Imaging-Potential of Isomeric Photosensitizers Derived from Chlorophyll-a and Bacteriochlorophyll-aJournal of Medicinal Chemistry, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements*Published by Elsevier BV ,2010
- Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic TherapyMolecular Pharmaceutics, 2010
- Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance PhenotypeMolecular Cancer Therapeutics, 2010
- Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic DiagnosisAdvances in Pharmacological Sciences, 2010
- Structural Factors and Mechanisms Underlying the Improved Photodynamic Cell Killing with Silicon Phthalocyanine Photosensitizers Directed to Lysosomes Versus MitochondriaPhotochemistry and Photobiology, 2009
- Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neckOral Oncology, 2009
- Conjugation of 2-(1′-Hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to Carbohydrates Changes its Subcellular Distribution and Enhances Photodynamic Activity in VivoJournal of Medicinal Chemistry, 2009
- Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic TherapyClinical Cancer Research, 2008